Financial News
Pliant Therapeutics, Inc. - Common Stock (NQ:PLRX)
1.460
+0.020
(+1.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 758,159 |
| Open | 1.430 |
| Bid (Size) | 1.290 (10) |
| Ask (Size) | 1.450 (1) |
| Prev. Close | 1.440 |
| Today's Range | 1.410 - 1.507 |
| 52wk Range | 1.100 - 16.52 |
| Shares Outstanding | 35,937,937 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What's going on in today's after hours session
March 10, 2025
Here are the top movers in Monday's session.
March 03, 2025
Which stocks are gapping on Monday?
March 03, 2025
Unusual volume stocks in Wednesday's session
February 12, 2025
Frequently Asked Questions
Is Pliant Therapeutics, Inc. - Common Stock publicly traded?
Yes, Pliant Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Pliant Therapeutics, Inc. - Common Stock trade on?
Pliant Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pliant Therapeutics, Inc. - Common Stock?
The ticker symbol for Pliant Therapeutics, Inc. - Common Stock is PLRX on the Nasdaq Stock Market
What is the current price of Pliant Therapeutics, Inc. - Common Stock?
The current price of Pliant Therapeutics, Inc. - Common Stock is 1.460
When was Pliant Therapeutics, Inc. - Common Stock last traded?
The last trade of Pliant Therapeutics, Inc. - Common Stock was at 04/17/25 04:00 PM ET
What is the market capitalization of Pliant Therapeutics, Inc. - Common Stock?
The market capitalization of Pliant Therapeutics, Inc. - Common Stock is 52.47M
How many shares of Pliant Therapeutics, Inc. - Common Stock are outstanding?
Pliant Therapeutics, Inc. - Common Stock has 52M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
